Genuv Inc.
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Trial of Safety, Tolerability and Efficacy of Trametinib (SNR1611) in Patients With Amyotrophic Lateral Sclerosis (ALS) (NCT04326283) | Genuv Inc. | 2020-04-02 |
Track Genuv Inc. automatically
Every clearance here is in the API, with alerts when new ones post.